Abstract:Purpose/Aim
Subretinal drusenoid deposits (SDD) are the main structural lesion of reticular macular disease (RMD), a phenotype of age-related macular degeneration (AMD). We aim to demonstrate spatiotemporal relationships between SDD and choroidal thickness alterations in RMD+ and RMD− eyes.
Materials and Methods
33 eyes (26 subjects) with early AMD/no SDD (RMD−) and 18 eyes (16 subjects) with early AMD/SDD (RMD+) underwent enhanced depth imaging spectral domain optical coherence tomography for choroidal thic… Show more
“…Similar to and supporting our findings, Cheng et al . found that mean ChT was significantly thinner in RPD eyes prior to adjustment but this result was no longer significant when adjusting for variables such as age and axial length . Similarly, Thorell et al .…”
Section: Discussionmentioning
confidence: 93%
“…This was similar to Cheng et al . whom studied ChT in eyes with early AMD with and without RPD . They found that those with RPD were older and composed of more females when compared to the non‐RPD group.…”
Section: Discussionmentioning
confidence: 99%
“…Cheng et al . further dichotomized their group by median age of all subjects . They found that among subjects ≤82 years old, eyes with RPD had significantly thinner choroids than AMD eyes without RPD, suggesting that the effects of RPD on ChT occur earlier in the AMD process as there was no difference in ChT in the ≥ 82 year old group.…”
Section: Discussionmentioning
confidence: 99%
“…These studies however are often limited either by a small sample size, a cohort with various stages of AMD or had elements of selection bias, or did not adequately adjust for variables known to influence ChT such as age and refractive error . There has also been one study that did not find a clear association between ChT and RPD …”
Age and refractive error, rather than RPD, was significantly associated with reduced ChT in eyes with iAMD. Choroidal insufficiency may be a less important variable in RPD aetiology than previously considered.
“…Similar to and supporting our findings, Cheng et al . found that mean ChT was significantly thinner in RPD eyes prior to adjustment but this result was no longer significant when adjusting for variables such as age and axial length . Similarly, Thorell et al .…”
Section: Discussionmentioning
confidence: 93%
“…This was similar to Cheng et al . whom studied ChT in eyes with early AMD with and without RPD . They found that those with RPD were older and composed of more females when compared to the non‐RPD group.…”
Section: Discussionmentioning
confidence: 99%
“…Cheng et al . further dichotomized their group by median age of all subjects . They found that among subjects ≤82 years old, eyes with RPD had significantly thinner choroids than AMD eyes without RPD, suggesting that the effects of RPD on ChT occur earlier in the AMD process as there was no difference in ChT in the ≥ 82 year old group.…”
Section: Discussionmentioning
confidence: 99%
“…These studies however are often limited either by a small sample size, a cohort with various stages of AMD or had elements of selection bias, or did not adequately adjust for variables known to influence ChT such as age and refractive error . There has also been one study that did not find a clear association between ChT and RPD …”
Age and refractive error, rather than RPD, was significantly associated with reduced ChT in eyes with iAMD. Choroidal insufficiency may be a less important variable in RPD aetiology than previously considered.
“…Similarly, Cheng et al . reported that, after adjustment for age, mean ChT was not significantly thinner among eyes with RPD . However, they did find an association between RPD and ChT among participants who were less than 82 years old.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.